Sean Fu is the founder of RVAC Medicines. RVAC Medicines has raised $170M in total funding. Backed by CBC Group, Pavilion Capital, EDBI.
Sean Fu is the co-founder and CEO of RVAC Medicines, an mRNA platform company established in 2021. The company, headquartered in Singapore with R&D in Boston and Shanghai, focuses on developing innovative products for diseases with unmet medical needs. RVAC Medicines has raised $170 million in funding since its inception. Prior to this, Fu was Group VP and head of International R&D at Luye Pharma and CEO of GeneLeap, a Luye subsidiary.
Full founder directory · Investor directory · Company funding database · Fundraising library